Delivery Order SPE2DE21D7010-SPE2D626F19WE
- Not listed
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a $12,969.84 delivery order by the Defense Logistics Agency Medical Supply Chain on December 11, 2025, for MODULUS spinal surgical products. The contract utilizes a fixed-price structure with economic price adjustment provisions and carries no set-aside designation, indicating open market competition. Performance will be completed at Nuvasive's San Diego facility by December...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order valued at $11,287.94 by the Defense Logistics Agency Medical Supply Chain on November 13, 2025. The contract, designated as Delivery Order 4570101607, involves the procurement of MODULUS spinal surgical products and is structured as a fixed-price agreement with economic price adjustment provisions to accommodate cost fluctuations in specialized medical device...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order valued at $22,128.07 on November 25, 2025, for the supply of MODULUS spinal surgical products and related medical devices. This fixed-price contract with economic price adjustment mechanisms is scheduled for completion by January 2, 2026, with performance conducted at Nuvasive's San Diego, California facility. The contract was issued without set-aside...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a $11,287.94 delivery order (Contract No. 4570435995) by the Defense Logistics Agency Medical Supply Chain on December 31, 2025, with completion targeted for January 2, 2026. The contract utilizes a fixed-price structure with economic price adjustment mechanisms and involves the delivery of MODULUS spinal surgical products and related medical technologies to support federal...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order valued at $5,477.02 on December 4, 2025, for the MODULUS spinal surgical product through the Defense Logistics Agency (DLA) Medical Supply Chain. This fixed-price contract with economic price adjustment provisions is scheduled for completion by December 31, 2025, with performance occurring at Nuvasive's San Diego facility. The award carries no set-aside...
- Nuvasive, Inc., a San Diego-based medical device manufacturer specializing in spinal surgery products and services, has been awarded a delivery order valued at $22,408.89 by the Defense Logistics Agency (DLA) Medical Supply Chain on September 22, 2025. The contract, which carries no set-aside designation, is for the delivery of MODULUS spinal medical products and is structured as a fixed-price agreement with economic price adjustment provisions. Performance is scheduled to conclude by October...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order valued at $21,266.40 by the Defense Logistics Agency (DLA) Medical Supply Chain on December 10, 2025. This firm fixed-price delivery order with economic price adjustment mechanisms is scheduled for completion by December 31, 2025, and will be performed at Nuvasive's San Diego facility. The contract carries no set-aside designation, reflecting Nuvasive's...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, was awarded a delivery order valued at $1,956.60 on December 12, 2025, by the Defense Logistics Agency Medical Supply Chain. This fixed-price delivery order with economic price adjustment provisions is scheduled for completion by January 6, 2026, and involves the supply of MAXCESS spinal surgical products and related medical devices to support federal...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order valued at $9,642.60 by the Defense Logistics Agency Medical Supply Chain on December 11, 2025. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and carries no set-aside designation, reflecting successful competition in an open market procurement. The award is scheduled for completion by January 2, 2026, with...
- Nuvasive, Inc., a San Diego-based medical device company specializing in spinal surgery products and services, was awarded a delivery order valued at $1,956.60 by the Defense Logistics Agency Medical Supply Chain on May 8, 2025. This fixed-price delivery order with economic price adjustment mechanism carries an ultimate completion date of May 9, 2025, and is not associated with any set-aside designation, indicating open market competition. The contract supports the federal healthcare system's...
- SPE2DE21D7010Indefinite Delivery Contract
- SPE2DE21D7010-SPE2D626F19WEDelivery Order
Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order valued at $11,287.94 on January 8, 2026, for the supply of MODULUS spinal surgical products. This fixed-price delivery order with economic price adjustment mechanisms will be performed at Nuvasive's San Diego, California facility with an ultimate completion date of January 9, 2026. The contract was issued without set-aside designation through the Defense Logistics Agency Medical Supply Chain, which procures medical supplies and equipment for Department of Defense and Department of Veterans Affairs healthcare facilities. This award is issued against the parent company's $8 million Blanket Purchase Agreement with the Defense Health Agency, an Indefinite Delivery/Indefinite Quantity contract vehicle effective through March 2027 that enables streamlined procurement of Nuvasive's comprehensive portfolio of spinal medical devices, instruments, and biologics across DoD and VA medical facilities. Nuvasive has established itself as a critical supplier to federal healthcare agencies through sustained delivery of advanced spinal fusion devices, interbody implants, surgical instruments, and bone graft materials supporting complex orthopedic and neurosurgical procedures. The company's federal contract portfolio demonstrates successful competition in open market procurements across multiple funding agencies, with delivery order values historically ranging from under one hundred dollars to approximately seventy-one thousand dollars, typically completed within weeks to months to meet urgent military health system medical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.3k | 1/7/26 |